bioresearch | Bioresource Technology, Inc | biosb | Bioscience Incorporated | biosearch | biosearch technologies | biosearchtech | biosense laboratories | biosensis | biosera | bioserv | biosonda | biosource | biospacific | biospec | Biospec Products | bioss | biosupply | biosupply uk | Bio...
E-mail: k.naresh@imperial.ac.ukChrissy GilesAmin RahemtullaJohn Wiley & Sons, Ltd.British Journal of HaematologyByrne E, Naresh KN, Giles C, Rahemtulia A. Excess bon marro B-cells in patients with multiple myeloma achieving complete remission after autologous stemc cell transplant is a ...
The procedure's superiority was initially proven by the Intergroupe Fran- cophone du Myeloma (IFM) and later confirmed by the UK Medical Research Council5–8. Despite its confirmed significant impact on event-free survival (EFS), multiple trials failed to depict significant...
Liechtenstein, Norway, and Northern Ireland. NEXPOVIO(R) is also approved in the UK under a Conditional Marketing Authorisation. The extension of indication in combination
The rabbit RECQ1-mediated drug resistance in multiple myeloma E Viziteu et al 2105 anti-53BP1 antibody (clone NB100-304, Novus Biologicals, Cambridge, UK) and the mouse anti-γH2AX (Ser139) antibody (clone JBW301, Merck Millipore, Darmstadt, Germany) were diluted 1/300 and 1/100, ...
Then, cells were washed three times with washing buffer and incubated with monoclonal anti-M13 peroxidase conjugate antibody (Amersham Biosciences, Buckinghamshire, UK) at a dilution of 1/5000 in PBS + 1% lactalbumin + 0.1% Tween-20 (100 μL/well) for 1 h at 37 °C. Finally, cells were...
Then, cells were washed three times with washing buffer and incubated with monoclonal anti-M13 peroxidase conjugate antibody (Amersham Biosciences, Buckinghamshire, UK) at a dilution of 1/5000 in PBS + 1% lactalbumin + 0.1% Tween-20 (100 μL/well) for 1 h at 37 °C. Finally, cells were...